Forget the lipstick index — the new mood booster is a damn good hair day. As Australians grapple with rising costs of food and fuel, they're swapping expensive perfumes for home hair treatments, and the beauty industry is taking notice.
It's a classic economic pattern. Leonard Lauder, the late chairman of Estée Lauder, coined the "Lipstick Index" to describe how consumers cut back on big purchases during uncertainty but still splurge on small indulgences. In 2022, it was the Fragrance Index — luxury scents flying off shelves. Now, it's the Hair Index. Premium haircare sales in the US grew faster than fragrances in the first quarter of 2026, according to research group Circana.
L'Oréal, the world's biggest beauty company, saw haircare sales jump 12.9% in 2025, outpacing all other divisions.
But economics aren't the only driver. GLP-1 weight-loss drugs, like Ozempic, have been linked to hair thinning. Younger Australians are also openly discussing scalp health on TikTok and Reddit, breaking taboos around hair loss. The pandemic-era stress didn't help either — anxiety triggered hair loss for many, pushing them toward scalp treatments and serums.
The trend has its roots in lockdowns. When Dyson released the Airwrap in 2018, TikTok exploded with tutorials for achieving voluminous waves. Suddenly, hair became the new skincare — a process dubbed "skinification." Serums to nourish, heat sprays to protect, oils to tame frizz. L'Oréal says almost three-quarters of French women now use more than three haircare steps.
"Haircare has the potential to be the next big thing in beauty, offering an opportunity for expansion as explosive fragrance sales settle down to more pedestrian growth."
For Australian consumers, this means more options at the chemist or Sephora. Premium products currently make up just 25% of the haircare market, compared to 50% for skincare, according to L'Oréal. That gap signals room to grow. Brands are rushing in: L'Oréal owns Kérastase and Color Wow; Unilever has Living Proof and fast-growing K18; Henkel recently bought Olaplex for $1.4 billion; Estée Lauder's Aveda is winning customers with its Miraculous Oil. Even affordable lines like The Ordinary have launched hair serums.
The shift isn't just top-end. Jason Harcup, who leads R&D for Unilever's beauty arm, told the Financial Times that Dove's range for repairing inner hair fibres helped the mass-market brand's haircare sales grow by double digits in the first quarter — outpacing Unilever's overall hair sales. Science-backed and clinical lines are popping up across all price points, from $10 drugstore buys to $100 salon treatments.
Meanwhile, men are under more pressure than ever to look youthful. Cosmetic surgery is more acceptable, and hair transplants have lost their stigma. Turkey alone generates an estimated $1.4 billion annually from hair-transplant tourism. For Australians, that's a popular destination for a cheaper procedure, but local clinics are also seeing a boom.
Dry shampoo sales, which had been weak for a couple of years, are growing again as people refresh styles between washes. And with winter settling in, a good hair day might just be the cheapest pick-me-up going around.
So whether you're battling thinning hair from stress or drugs, or just want to feel a bit fancy without breaking the bank, you're not alone. The beauty giants are betting on your hair — and they're probably right.